Sixth Wave has completed testing of it AMIPS™, an advanced Molecular Imprinting Polymer (MIP) system, that will provide a single use, Rapid Virus Test for the selective identification of Covid-19 that can give easy-to-read results within minutes.
Test results based on saliva testing have verified sensitivity 250 times better than the best-in-class rapid antigen tests with no false alarms to a standardized battery of respiratory viruses and bacteria. Commercialization has begun and should result in the first and only non-molecular test (PCR or NAAT) capable of detecting individuals who are asymptomatic and contagious.
The flagship technology uses a branch of nanotechnology called Molecularly Imprinted Polymers (MIPS). MIPs are synthetic polymers uniquely designed to capture and detect target materials by templating or cloning the target molecule. These targets can be as small as parts-per-billion.
The Rapid Virus Test would be exposed to a bodily fluid (nasal swab, saliva or breath) of the potential carrier. The test rapidly determines SARS-CoV-2 infection by colorimetric, fluorometric or electrochemical methods. A simple binary (yes/no) test. The Rapid Virus Test would allow for high volume, point-of-use screening in public sector, private industry, hospitals, long-term healthcare facilities, and various forms of public transportation.
Sixth Wave has successfully developed the AMIPS™ platform so that it can be rapidly expanded to detect other viral and bacterial pathogens and can be multiplexed to detect multiple pathogens within a single test.